Jane Street Group, LLC Aurinia Pharmaceuticals Inc. Call Options Transaction History

Jane Street Group, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$5.32 - $7.33 $1.22 Million - $1.68 Million	228,800 New	228,800 $1.68 Million
Q1 2022 May 17, 2022	SELL	$10.05 - $22.48 $5.36 Million - $12 Million	-533,300 Reduced 31.21%	1,175,400 $14.6 Million
Q4 2021 Feb 15, 2022	SELL	$17.78 - $33.08 $542,290 - $1.01 Million	-30,500 Reduced 1.75%	1,708,700 $39.1 Million
Q3 2021 Nov 16, 2021	BUY	$10.93 - $23.55 $15.4 Million - $33.2 Million	1,411,600 Added 430.89%	1,739,200 $38.5 Million
Q2 2021 Aug 16, 2021	BUY	$10.0 - $14.52 $1.85 Million - $2.69 Million	185,200 Added 130.06%	327,600 $4.25 Million
Q1 2021 May 18, 2021	SELL	$12.3 - $18.73 $504,300 - $767,930	-41,000 Reduced 22.36%	142,400 $1.85 Million
Q4 2020 Feb 17, 2021	BUY	$12.94 - $16.05 $1.76 Million - $2.18 Million	136,000 Added 286.92%	183,400 $2.54 Million
Q3 2020 Nov 17, 2020	BUY	$13.19 - $16.66 $32,975 - $41,650	2,500 Added 5.57%	47,400 $698,000
Q2 2020 Aug 17, 2020	BUY	$14.12 - $18.33 $52,244 - $67,821	3,700 Added 8.98%	44,900 $730,000
Q1 2020 May 15, 2020	BUY	$11.34 - $21.46 $140,616 - $266,104	12,400 Added 43.06%	41,200 $598,000
Q4 2019 Feb 14, 2020	BUY	$3.88 - $21.42 $111,744 - $616,896	28,800 New	28,800 $583,000

209

58.7M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.15B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.